Clinical Trial Update: A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin [Phase 2]

View source ↗

Summary

Phase 2 study evaluating once-daily NNC0090-2746 in adults with type 2 diabetes inadequately controlled on metformin (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NNC0090-2746

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus Type 2 | Phase 2 | Status: COMPLETED